Reply to 'Treatment of Essential Telangiectasia': Use of Polidocanol.
Reynolds
O
O
D006801:Humans; D006982:Hypertonic Solutions / Q000627:therapeutic use; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use; D013684:Telangiectasis / Q000628:therapy*
D006982:Hypertonic Solutions; D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D012965:Sodium Chloride